Paloma Partners’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-63,790
Closed -$435K 1302
2024
Q2
$435K Buy
+63,790
New +$275K 0.01% 804
2020
Q3
Sell
-7,692
Closed -$608K 2167
2020
Q2
$608K Buy
+7,692
New +$573K 0.01% 1144
2020
Q1
Sell
-4,480
Closed -$242K 1450
2019
Q4
$242K Sell
4,480
-4,997
-53% -$271K ﹤0.01% 1880
2019
Q3
$495K Buy
9,477
+4,827
+104% +$225K 0.01% 1167
2019
Q2
$225K Buy
4,650
+34
+0.7% +$1.63K ﹤0.01% 1476
2019
Q1
$233K Buy
+4,616
New +$272K 0.01% 1437
2017
Q2
Sell
-12,586
Closed -$366K 2229
2017
Q1
$366K Sell
12,586
-14,683
-54% -$447K ﹤0.01% 1681
2016
Q4
$895K Buy
27,269
+14,733
+118% +$442K 0.01% 1233
2016
Q3
$395K Sell
12,536
-25,439
-67% -$739K ﹤0.01% 1508
2016
Q2
$1.07M Buy
37,975
+18,736
+97% +$735K 0.01% 1108
2016
Q1
$699K Buy
+19,239
New +$680K 0.01% 1115

Other funds holding EBS